European Congress on Biotochnology, Maastricht, 9-12 May 2021
IBS2021, ECB2021 and NBC-21 will showcase frontline science that will form the basis for future commercial innovation. The scientific programme reveals an excellent line-up of plenary lectures and invited speakers. In line with the IBS and ECB tradition, we will promote the participation of young scientists by encouraging them to submit their original work to be considered for presentation as short talks or posters.
European Congress on Biotochnology
Maastricht, The Netherlands
9-12 May 2021
www.ecb2021.com
Abstract Submissions Are Open!
Invited Talks available for selection from submitted abstracts.
Abstracts can be submitted for either poster or oral presentation until 1 February 2021. Submissions from IBS and AFOB colleagues outside Europe are especially welcome: Japan, Korea, China, Taiwan, Indonesia, India, Pakistan, USA, South Africa, Australia, New Zealand.
Important Dates
- 1 February 2021 - Abstract submission ends
- 3 February 2021 - End of early bird registration
- March 2021 - Abstract acceptance notification & confirmation
- 9 May 2021 - Congress opens
- 12 May 2021 - Congress closes
Contacts
Website: www.ecb2021.com
Email:
David Spichiger, SCS
04.08.2020
ChemBioChem: Virtual Symposia in July 2020
EurJOC and ChemBioChem are proud to host the next round of virtual symposia in July:
Featuring three great presentations by:
Gilles Gasser (Chimie ParisTech)
“Selective Delivery of Ruthenium-based Photosensitizers for Photodynamic Therapy”
Seth Cohen (UC San Diego)
“The Development of Metal-Binding Isosteres for Fragment-Based Drug Discovery”
Marie Heffern (UC Davis)
“Untangling the Extracellular Bioinorganic Space and its Implications in Health”
Free Registration here.
Featuring three great presentations by:
Varinder Aggarwal (University of Bristol) “Assembly Line Synthesis”
Tatiana Besset (INSA de Rouen, Université de Rouen) “Sulfur and Fluorine: An Efficient Partnership”
Josep Cornellà (MPI für Kohlenforschung) “New Catalysts and Reagents for Organic Synthesis”
Free Registration here.
Céline Wittwer, SCS
23.06.2020
1st ChemBioChem Virtual Symposium
1st ChemBioChem Virtual Symposium
May 27, 2020 - 3-5pm
Virtual Room
Registration free of charge: workcast.com/register
The ChemBioChem editorial team is proud to host the 1st ChemBioChem Virtual Symposium! Please join them and their three speakers Tom Grossmann (VU Amsterdam), Alison Narayan (University of Michigan), and Gonçalo Bernardes (University of Cambridge) for this event.
Tom Grossmann (VU Amsterdam) “In Situ Cyclization of Proteins (INCYPRO) – Stabilizing protein tertiary structures with synthetic scaffolds”
Alison Narayan (University of Michigan “Biocatalysis and complex molecule synthesis”
Goncalo Bernardes (University of Cambridge) “Translational antibody bioconjugation”
Free registration now on: workcast.com
Céline Wittwer, SCS
25.05.2020
International Symposium on Chemical Biology, January 22-24, 2020, Geneva
International Symposium on Chemical Biology
January 22-24, 2020
Campus Biotech, 9 Chemin des Mines, 1211, Geneva
http://symposium.nccr-chembio.ch/
This major international event that is organized by the NCCR Chemical Biology will bring together leading scientists, comprising two keynote speakers (Prof. Laura Kiessling (MIT) and Prof. Giulio Superti-Furga (CeMM)) and thirteen outstanding speakers who will collectively cover topics around the engineering of proteins and small molecules, chemogenetic and optogenetic technologies for probing molecular and cellular interactions, technologies to probe active molecules in their native environment, etc.
The aim of this international event is to learn more about the latest advances in the field of chemical biology and to foster an open and dynamic dialogue amongst the scientists conducting this exciting research.
Registration / Travel Grants
Registration is open until December 16, 2019.
Fee waiver/travel grant fellowships are available. The event will also include a Poster & Young researcher prize session.
Contact
Prof. Howard Riezman, Director NCCR Chemical Biology (UNIGE)
Prof. Christian Heinis, Co-director NCCR Chemical Biology (EPFL)
NCCR Chemical Biology
University of Geneva
Quai Ernest-Ansermet 30
1211 Geneva 4 - Switzerland
www.nccr-chembio.ch
Website
http://symposium.nccr-chembio.ch/
David Spichiger, SCS
15.10.2019
Peptide Therapeutics Forum @ Basel Life, 11.-12.09.19
Congress Center Basel, 10 - 11 September 2019
Chairs
Thomas Vorherr (Novartis Pharma AG, Basel, Switzerland)
Roderich Süssmuth (Technical University of Berlin, Germany)
Tuesday, 10 September 2019
| 10.00 | Playmolecule, a repository of deep learning based applications for biomolecule design Franck Chevalier (Acellera, Barcelona, Spain) |
| 10.30 | Optimization of the lipopeptide arylomycin natural product into Gram-negative antibiotics Christopher Heise (Genentech Research & Early Development, San Francisco, United States) |
| 11.00 | Break |
| 11.30 | Activation of the Hippo pathway via targeting of transcription factor TEAD using designed tertiary protein structure mimetics Helene Adihou (Astra Zeneca, Dortmund, Germany) |
| 12.00 | Elimination of Aβ oligomers by the orally available all-D-peptide PRI-002 reverses cognition deficits and decelerates neurodegeneration Dieter Willbold (University of Düsseldorf, Germany) |
| 12.30 | Lunch break and Industry Symposium |
| 14.00 | PLENARY LECTURE The chemical evolution of endocrine hormones Richard DiMarchi (University of Indiana, Bloomington, United States) |
| 15.00 | Break |
| 15.30 | Peptide platforms for therapy and imaging: The first total synthesis of amanitin for ADCs and one-step 18F-labeling PET-oncology David Perrin (University of British Columbia, Vancouver, Canada) |
| 16.00 | Virobiome derived anti-inflammatory short peptides Michael Ruff (Creative BioPeptides) |
Wednesday, 11 September 2019
| 10.00 | Exotic side chain-to-side-chain cyclization modes in octreotide analogs for tumor pretargeting Anna Maria Papini (University of Florence, Italy) |
| 10.30 | Peptide-based radiopharmaceuticals for cancer imaging and therapy Agonist or Antagonist? Does it really matter? Melpomeni Fani (University Hospital Basel, Switzerland) |
| 11.00 | Break |
| 11.30 | Vancomycin regains effectiveness for resistant bacteria by conjugation to cationic peptides Walter Mier (University of Heidelberg, Germany) |
| 12.00 | Peptide discovery at protagonist therapeutics: A platform yielding multiple clinical candidates Mark Smythe (Protagonist, Newark, United States) |
| 12.30 | Lunch break and Industry Symposium |
| 14.00 | Disulfide-rich peptide production Mike Pennington (AmbioPharm, North Augusta, United States) |
| 14.30 | A new green solvent for solid phase peptide synthesis Jon Collins (CEM, Matthews, United States) |
| 15.00 | Break |
| 15.30 | Synthetic immune system engagers target cancer cells and prevent tumor formation Christian Becker (University of Vienna, Austria) |
| 16.00 | Discovery and clinical development of an inhaled cyclic peptide elastase inhibitor for the treatment of cystic fibrosis Roxana Drake & Marc Thommen (Santhera Pharmaceuticals CH Ltd., Pratteln, Switzerland) |
The programme indicated maybe subject to change!
Website Basel Life: https://www.basellife.org/
David Spichiger, SCS
17.04.2019
Page 268 of 297